Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,796 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Danesi V, Massa I, Foca F, Delmonte A, Crinò L, Bronte G, Ragonesi M, Maltoni R, Manunta S, Cravero P, Andrikou K, Priano I, Balzi W, Gentili N, Burke T, Altini M. Danesi V, et al. Among authors: burke t. Cancers (Basel). 2022 Sep 15;14(18):4481. doi: 10.3390/cancers14184481. Cancers (Basel). 2022. PMID: 36139641
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan.
Goto Y, Tamura A, Matsumoto H, Isobe K, Ozaki T, Santorelli ML, Taniguchi K, Kamitani T, Irisawa M, Kanda K, Abe M, Burke T, Nokihara H. Goto Y, et al. Among authors: burke t. JTO Clin Res Rep. 2022 Aug 5;3(9):100397. doi: 10.1016/j.jtocrr.2022.100397. eCollection 2022 Sep. JTO Clin Res Rep. 2022. PMID: 36065450 Free PMC article.
1,796 results